NCT04282252View on ClinicalTrials.gov

The Effect of Restrictive Fluid Management on Cardiac Function and Glycocalyx Degradation

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 2, 2020

Primary Completion Date

October 22, 2021

Study Completion Date

April 22, 2022

Conditions
Septic Shock
Interventions
DRUG

I.V. SOLUTIONS

All i.v. fluids used in an Intensive Care Unit.

Trial Locations (1)

11883

Södersjukhuset, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT04282252 - The Effect of Restrictive Fluid Management on Cardiac Function and Glycocalyx Degradation | Biotech Hunter | Biotech Hunter